Innovative drug delivery in ophthalmology

Ocular drug delivery (topical or intraocular) is hindered by physiological barriers, including the mucus layer, surface epithelium, tear drainage, enzyme metabolism, and the blood–aqueous and blood–retina barriers. Conventional dosage forms face problems related to short retention time and poor drug bioavailability. The development of nanoparticles as drug delivery systems is an advantageous strategy that could overcome these limitations. Nanoparticles can prolong the retention time on the ocular surface, allowing more effective contact with the epithelium. In addition, they can reduce the side effects of drugs due to their capability to release the drug at a desired rate. Finally, nanoparticles can improve the solubility of poorly water-soluble drugs, further enabling their absorption. The present review summarizes recent research on the development of three types of nanoparticles as carriers for ophthalmic drug delivery, particularly polymeric micelles, nanogels, and nanocrystals.

• Publication year

  2025

• Venue

  Pharmacia

• Publication date

  2025-09-26

• Fields of study

  Not labeled

• Identifiers
  DOI 10.3897/pharmacia.72.e168905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chitosan-TPP Nanogels for Ocular Delivery of Folic Acid: Release Profile, Corneal Permeation, and Mucoadhesion Assessment

  2025cited by this paper
• Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment.

  2025cited by this paper
• Nanogels—Innovative Drug Carriers for Overcoming Biological Membranes

  2025cited by this paper
• Chondroitin Sulphate-Chitosan Based Nanogels Loaded with Naringenin-β-Cyclodextrin Complex as Potential Tool for the Treatment of Diabetic Retinopathy: A Formulation Study

  2025cited by this paper
• Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization.

  2024cited by this paper
• Enhanced Ocular Delivery of Beva via Ultra‐Small Polymeric Micelles for Noninvasive Anti‐VEGF Therapy

  2024cited by this paper
• Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy.

  2024cited by this paper
• Injectable nanogels to improve triamcinolone acetonide delivery and toxicity on the treatment of eye diseases

  2024cited by this paper
• Polymeric Mixed Micelle-Loaded Hydrogel for the Ocular Delivery of Fexofenadine for Treating Allergic Conjunctivitis

  2024cited by this paper
• Recent advances in nanocrystal-based technologies applied for ocular drug delivery

  2024cited by this paper
• Nanotechnology-based ocular drug delivery systems: recent advances and future prospects

  2023cited by this paper
• Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration

  2023cited by this paper
• Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.

  2023cited by this paper
• Pluronic®/casein micelles for ophthalmic delivery of resveratrol: in vitro, ex vivo, and in vivo tests.

  2022cited by this paper
• Hyaluronan-Cholesterol Nanogels for the Enhancement of the Ocular Delivery of Therapeutics

  2021cited by this paper
• Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and in vivo evaluation in a rabbit ocular inflammatory model

  2020cited by this paper
• The generation of fluorometholone nanocrystal eye drops, their metabolization to dihydrofluorometholone, and penetration into rabbit eyes.

  2020influential reference
• Benefits and Perspectives of Nanoparticles Based on Chitosan and Sodium Alginate

  2020cited by this paper
• Micelle-nanogel platform for ferulic acid ocular delivery.

  2019cited by this paper
• Nanogel loaded with surfactant based nanovesicles for enhanced ocular delivery of acetazolamide

  2019cited by this paper
• Imatinib-Loaded Micelles of Hyaluronic Acid Derivatives for Potential Treatment of Neovascular Ocular Diseases.

  2018cited by this paper
• Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery.

  2018cited by this paper
• Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome

  2017cited by this paper
• Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma.

  2017cited by this paper
• Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: In vitro characterization and in vivo permeation

  2017cited by this paper
• Why Chitosan? From properties to perspective of mucosal drug delivery.

  2016cited by this paper
• Nanoparticles for Ocular Drug Delivery

  2016cited by this paper
• Nanocrystal for ocular drug delivery: hope or hype

  2016cited by this paper
• Self-Assembled Thermoresponsive Nanogels Prepared by Reverse Micelle → Positive Micelle Method for Ophthalmic Delivery of Muscone, a Poorly Water-Soluble Drug.

  2016cited by this paper
• α-Lipoic Acid in Soluplus(®) Polymeric Nanomicelles for Ocular Treatment of Diabetes-Associated Corneal Diseases.

  2016cited by this paper
• Development of cationic nanocrystals for ocular delivery.

  2016cited by this paper
• Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies

  2016cited by this paper
• Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.

  2014cited by this paper
• Stabilized micelles as delivery vehicles for paclitaxel.

  2012cited by this paper
• Diclofenac/biodegradable polymer micelles for ocular applications.

  2012cited by this paper
• Applications of nanoparticles in ophthalmology.

  2010cited by this paper
• Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy

  2010cited by this paper

• No citing papers are available for this paper.